Drug recall · November 9, 2016
Desoximetasone Cream USP recall
Why: Failed Stability Specifications: The subject lots exhibited OOS results for Homogeneity test (Moderate separation).
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Desoximetasone Cream USP, 0.25% 100 g, Rx only, mfd. by Taro Pharmaceuticals Inc. Brampton, Ontario, Canada L6T 1C1, Dist. by: Taro Pharmaceuticals U.S.A., Inc. Hawthorne, NY 10532; NDC 51672-1270-7
- Lots / codes
Lot #: B5093-18608, B5094-18608, Exp. Jan 2017; Lot #: C5141-18954, C5142-18954, E5109-19625, Exp . Feb 2017
- Quantity
- 15,576 units
- Company
- Taro Pharmaceuticals, Inc., Brampton
- Distribution
- US & Puerto Rico
- Initiated
- September 13, 2016 · Voluntary: Firm initiated
- Classified
- November 1, 2016
- Reported
- November 9, 2016
- Ended
- June 15, 2018
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Desoximetasone
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.